Page 5 - Johnc Klock News Today

AIA Group Ltd lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 168.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,313 shares of the biotechnology company’s stock after purchasing an additional 2,707 shares during the quarter. AIA Group Ltd’s […]

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) has received a consensus rating of “Hold” from the twenty-three research firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating on the company. […]

China Universal Asset Management Co. Ltd. lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 13.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 25,930 shares of the biotechnology company’s stock after selling 3,938 shares during the period. China Universal Asset Management […]

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) CEO Jean Jacques Bienaime sold 10,000 shares of the stock in a transaction that occurred on Thursday, April 6th. The stock was sold at an average price of $96.13, for a total value of $961,300.00. Following the completion of the sale, the chief executive officer now owns 425,896 […]

Rice Hall James & Associates LLC grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 63.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 34,408 shares of the biotechnology company’s stock after purchasing an additional […]

Manning & Napier Group LLC decreased its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 6.1% during the fourth quarter, HoldingsChannel reports. The firm owned 874,566 shares of the biotechnology company’s stock after selling 57,225 shares during the period. BioMarin Pharmaceutical makes up approximately 1.1% of Manning & Napier Group LLC’s […]

CAPROCK Group Inc. bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 1,947 shares of the biotechnology company’s stock, valued at approximately $201,000. A number of other hedge funds have also made changes to their positions in the company. Vanguard Group […]

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 6,110,000 shares, a drop of 16.1% from the February 28th total of 7,280,000 shares. Approximately 3.4% of the shares of the company are sold […]

Grandfield & Dodd LLC grew its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 7.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 15,410 shares of the biotechnology company’s stock after buying an additional 1,037 shares during the quarter. Grandfield […]

Rothschild Investment Corp IL lessened its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 2.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,254 shares of the biotechnology company’s stock after selling 406 shares during the quarter. Rothschild Investment Corp […]